Stick With Biolase Inc (BIOL). The Bull Are Alive And Well
Currently, there are 30.80M common shares owned by the public and among those 29.06M shares have been available to trade. The company’s stock has a 5-day price change of 29.09% and -84.13% over the past three months. BIOL shares are trading -84.02% year to date (YTD), with the 12-month market performance down to -99.47% lower. […]
Biolase Inc (NASDAQ: BIOL): Analyst View Points To Future Growth
Biolase Inc (BIOL) concluded trading on Wednesday at a closing price of $0.15, with 6.14 million shares of worth about $0.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.87% during that period and on March 20, 2024 the price saw a gain […]
Biolase Inc (NASDAQ: BIOL): Reassessing Prospects
Biolase Inc (BIOL) concluded trading on Wednesday at a closing price of $0.14, with 4.04 million shares of worth about $0.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -97.03% during that period and on on Wednesday the price saw a loss of […]
Biolase Inc (NASDAQ: BIOL): The Best-Of-Breed For Investing?
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling […]
Biolase Inc (BIOL) Volatility Spurs A Quest For Clarity
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling […]
